---
title: "Bruhn Suzanne Louise — Ownership Dossier"
canonical: https://whiteintel.dev/entity/3770a216-66e3-5e92-adbb-ca068c8e9ea2
json: https://whiteintel.dev/api/public/dossier/3770a216-66e3-5e92-adbb-ca068c8e9ea2
identifier: sec:0001517790
jurisdiction: US
risk: Low
source: WhiteIntel corporate-ownership graph
---

# Bruhn Suzanne Louise

**Type:** Person  
**Jurisdiction:** [US](https://whiteintel.dev/jurisdictions/us)  
**Identifier:** `sec:0001517790`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/3770a216-66e3-5e92-adbb-ca068c8e9ea2  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/3770a216-66e3-5e92-adbb-ca068c8e9ea2  

## Ownership & control

### Holdings / subsidiaries

- **Vigil Neuroscience, Inc.** (director) — https://whiteintel.dev/entity/dd4bafe3-c407-5c5a-9484-16d939ab9a60
- **Mind Medicine (MindMed) Inc.** (director) — https://whiteintel.dev/entity/0ee51bf8-967b-5932-81ef-f9208816b1b9
- **Travere Therapeutics, Inc.** (director) — https://whiteintel.dev/entity/e2547567-65d0-5b5e-abbc-2118894e9ff3
- **Vigil Neuroscience, Inc.** (director) — https://whiteintel.dev/entity/dd4bafe3-c407-5c5a-9484-16d939ab9a60
- **PLIANT THERAPEUTICS, INC.** (director) — https://whiteintel.dev/entity/b6f6099d-b132-5a0b-abe6-4b1af79a4d10
- **Avalo Therapeutics, Inc.** (director) — https://whiteintel.dev/entity/7ab53ad5-4202-5e5d-afb7-054c499320ac
- **Spyre Therapeutics, Inc.** (director) — https://whiteintel.dev/entity/bf7dce76-8d4f-5fee-ba09-97415a847c12
- **NOVELION THERAPEUTICS INC.** (director) — https://whiteintel.dev/entity/f3d6a7ec-1c7e-5acd-bff3-e233da0facbe
- **AXONYX INC** (director) — https://whiteintel.dev/entity/475650f2-862f-5bc8-8ed7-ba37654cc1c1

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **Bruhn Suzanne Louise**. Human view: https://whiteintel.dev/entity/3770a216-66e3-5e92-adbb-ca068c8e9ea2 · Structured JSON: https://whiteintel.dev/api/public/dossier/3770a216-66e3-5e92-adbb-ca068c8e9ea2._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._